What is food noise? Five theories

Food noise is the phrase people use for persistent, intrusive and unwanted thoughts about food. It spread through TikTok and Reddit alongside discussion of GLP-1 receptor agonist medicines such as semaglutide and tirzepatide, because users kept reporting the same thing. The noise got quieter^[1]. A theoretical review published in Appetite on 22 September 2026, from a team at Macquarie University in Sydney and American University in Washington DC, takes the term seriously enough to ask the awkward question underneath it. What is food noise, actually? The honest answer is that nobody has settled it yet^[1].

Where the term came from

The review describes food noise as a preoccupation with food that can be persistent, intrusive and unwanted^[1]. That description came out of social media and patient reports rather than a laboratory, which is unusual for something now discussed in obesity clinics. Qualitative research the authors synthesise describes the reduction people experience on a GLP-1 medicine such as semaglutide as welcome, and as something that gives them more control over their eating habits^[1]. The authors treat that as a promising effect of treatment rather than a settled finding. Their stated starting point is that little is known about what exactly food noise is, what causes it, or how any easing of those distressing thoughts would work^[1].

The five theories on the table

Rather than pick a winner, the review sets out five potential theoretical explanations and then synthesises them: homeostatic theory, food cue reactivity, food addiction, thought suppression, and memory inhibition^[1]. Each predicts something different about who experiences food noise and what would quieten it, which is why the choice is not academic housekeeping.

Homeostatic theory is the plainest reading. Thoughts about food track the body's energy state, so the noise is ordinary hunger signalling turned up loud. That would explain why medicines that change satiety signalling, including tirzepatide and semaglutide, appear to dial it down. Food cue reactivity moves the trigger outside the body, to the bakery window or the advert. A 2023 narrative review from Penn State and Dartmouth proposed a framework for exactly this, the Cue-Influencer-Reactivity-Outcome model, built to give food noise research the structure it was missing^[2].

The food addiction account borrows from substance-use research and reads repetitive food thoughts as craving. Thought suppression points in the opposite direction. Trying hard not to think about food, which is what most restrictive dieting asks of people, tends to make the thought return more often, so the noise would be partly a product of the effort to silence it. Memory inhibition, the fifth, looks at whether food-related memories are normally held in check between meals and what happens when that braking weakens. Those five are not mutually exclusive, and the review ends by combining them and setting out what future research would need to test^[1].

What the GLP-1 data actually shows

The strongest numbers so far come from surveys, not trials. The INFORM survey, published in Advances in Therapy in August 2026, asked 550 US adults using injectable semaglutide for weight management to complete a five-item Food Noise Questionnaire^[4]. Median scores fell from 13 out of a possible 20 before treatment to 6 after it, and the share of people agreeing with statements indicating food noise dropped from a range of 47 to 63 percent down to 15 to 20 percent^[4].

The design deserves as much attention as the numbers do. Participants scored their pre-treatment food noise from memory, the panel was 86 percent women with a mean age of 53, and several of the authors are Novo Nordisk employees^[4]. The authors say themselves that prospective, longitudinal research is needed to characterise the effect properly^[4]. We have not found an equivalent published survey for tirzepatide or retatrutide, though both come up constantly in the same online conversations.

The measurement problem

A commentary in Appetite, published online in July 2026 by researchers at Arizona State, Penn State, King's College London and the University of Sao Paulo, puts the objection bluntly^[3]. Dedicated food noise measurement tools have already appeared, but the evidence on what they measure has not caught up with them. The authors question whether food noise is a distinct phenomenon at all, or an overlapping dimension of processes the literature already describes as food cue reactivity, food preoccupation, cravings and intrusive food-related thoughts^[3]. They also flag something that matters to anyone recognising themselves in the term. A construct this loose carries the potential to reclassify a common experience as pathology^[3]. Their position is not that food noise is meaningless. It is that conceptual, methodological and normative clarity is needed before food noise is responsibly integrated into clinical use^[3].

What we don't yet know

Three gaps stand out in the current evidence. There is still no agreed definition, so no medicine can be said to fix food noise the way a blood-glucose reading gets fixed. There is no confirmed mechanism either, only five candidate explanations that have not been tested against each other^[1]. And there is an open safety question at the edge of all this. A 2026 article in the International Journal of Eating Disorders argues that the same mechanisms which reduce appetite and food preoccupation may, in vulnerable people, reinforce restriction, avoidance of regular eating and compulsive weight control, and it calls for routine eating disorder screening before and during treatment with a GLP-1 medicine^[5].

For readers, the practical takeaway is smaller than the headlines. A quieter head around food is a real and widely reported experience, it is now being measured with instruments that are themselves under review, and the reason it happens is genuinely unsettled. If you are considering one of these medicines, the eating-disorder screening conversation belongs with your prescriber, alongside the country-specific prescribing rules set out on our semaglutide regulation page and our tirzepatide page. This article is for educational and journalistic purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, changing or stopping any peptide medicine.